Search Results - "Guignard, N"

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections by Decosterd, L.A., Mercier, T., Ternon, B., Cruchon, S., Guignard, N., Lahrichi, S., Pesse, B., Rochat, B., Burger, R., Lamoth, F., Pagani, J.-L., Eggimann, P., Csajka, C., Choong, E., Buclin, T., Widmer, N., André, P., Marchetti, O.

“…•Robust HPLC-MS/MS quantification of plasma levels of 12 daily-used antibiotics.•Directly covering the entire clinically relevant ranges of…”
Get full text

Functionalizing Effect of Increasingly Graphitic Carbon Supports on Carbon-Supported and TiO2–Carbon Composite-Supported Pt Nanoparticles by Ma, J, Habrioux, A, Guignard, N, Alonso-Vante, N

“…Strong interaction between Pt nanoparticles and graphitic carbon in carbon-based and oxide–carbon composite substrates is demonstrated using electrochemical CO…”
Get full text

Effect of gradual reduction of graphene oxide on the CO tolerance of supported platinum nanoparticles by Abidat, I., Morais, C., Pronier, S., Guignard, N., Comparot, J.D., Canaff, C., Napporn, T.W., Habrioux, A., Mamede, A.-S., Lamonier, J.-F., Kokoh, K.B.

“…Gradually reduced graphene oxide materials were successfully synthesized by performing successive chemical treatments on graphite oxide synthesized using…”
Get full text

Corrigendum to “Validation and clinical application of a multiplex high performance liquid chromatography – Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections” [J. Chromatogr. B 1157 (2020) 122160] by Decosterd, L.A., Mercier, T., Ternon, B., Cruchon, S., Guignard, N., Lahrichi, S., Pesse, B., Rochat, B., Burger, R., Lamoth, F., Pagani, J.-L., Eggimann, P., Csajka, C., Choong, E., Buclin, T., Widmer, N., André, P., Marchetti, O.

Get full text

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine by Fayet, A., Béguin, A., Zanolari, B., Cruchon, S., Guignard, N., Telenti, A., Cavassini, M., Günthard, H.F., Buclin, T., Biollaz, J., Rochat, B., Decosterd, L.A.

“…Raltegravir (RAL), maraviroc (MVC), darunavir (DRV), and etravirine (ETV) are new antiretroviral agents with significant potential for drug interactions. This…”
Get full text

Sphenoidal sinogenic extradural empyema associated with juvenile myelomonocytic leukemia by Guignard, N., Roujeau, T., Saumet, L., Gascou, G., Mondain, M., Akkari, M.

“…Intracranial empyema is a rare but serious complication of sinusitis in children. Myelodysplastic/myeloproliferative syndromes (MMS), including juvenile…”
Get full text

Gardner's syndrome presenting with a fibromatous tumour of the parotid by Guignard, N, Cartier, C, Crampette, L, Akkari, M

“…Abstract Introduction Gardner's syndrome is the association of familial adenomatous polyposis (FAP) with an anaphase promoting complex (APC) gene mutation and…”
Get full text

An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients by Dahmane, E., Mercier, T., Zanolari, B., Cruchon, S., Guignard, N., Buclin, T., Leyvraz, S., Zaman, K., Csajka, C., Decosterd, L.A.

“…There is increasing evidence that the clinical efficacy of tamoxifen, the first and most widely used targeted therapy for estrogen-sensitive breast cancer,…”
Get full text

Study of the efficacy of melatonin for auditory brainstem response (ABR) testing in children by Casteil, L, Viquesnel, A, Favier, V, Guignard, N, Blanchet, C, Mondain, M

“…Abstract Study objective To evaluate the efficacy of oral melatonin to induce sedation (natural sleep) while measuring auditory brainstem responses (ABR) in…”
Get full text

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction by COLOMBO, S, GUIGNARD, N, MARZOLINI, C, TELENTI, A, BIOLLAZ, J, DECOSTERD, L. A

“…An HPLC method previously described for the simultaneous assay of amprenavir, ritonavir, indinavir, saquinavir, nelfinavir and efavirenz is proposed here for…”
Get full text

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction by Colombo, S., Guignard, N., Marzolini, C., Telenti, A., Biollaz, J., Decosterd, L.A.

“…An HPLC method previously described for the simultaneous assay of amprenavir, ritonavir, indinavir, saquinavir, nelfinavir and efavirenz is proposed here for…”
Get full text

Photovoltaic power plants with hydraulic storage: Life-cycle assessment focusing on energy payback time and greenhouse-gas emissions - a case study in Spain by Lamnatou, Chr, Guignard, N., Chemisana, D., Cristofari, C., Debusschere, V.

“…•The life-cycle profiles of Photovoltaic (PV) power plants have been evaluated.•The proposed PV plants include hydraulic storage; Case study: Catalonia,…”
Get full text

Functionalizing Effect of Increasingly Graphitic Carbon Supports on Carbon-Supported and TiO 2 –Carbon Composite-Supported Pt Nanoparticles by Ma, J., Habrioux, A., Guignard, N., Alonso-Vante, N.

Get full text

Catalytic activity insight into sustainable Fe-hydroxyapatite application using an experimental design approach by Bouzalekh, MY, Kouachi, K., Fontaine, C., Guignard, N., Taouti, M.B., Trari, M., Lafaye, G.

“…Combining experimental design with advanced characterisation methods provides a valuable opportunity to deepen our understanding of catalytic processes and…”
Get full text

Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration by Fayet Mello, Aurélie, Buclin, Thierry, Franc, Claudia, Colombo, Sara, Cruchon, Sandra, Guignard, Nicole, Biollaz, Jérôme, Telenti, Amalio, Decosterd, Laurent A., Cavassini, Matthias

“…Objectives The site of pharmacological activity of raltegravir is intracellular. Our aim was to determine the extent of raltegravir cellular penetration and…”
Get full text

Optimization of homonuclear 2D NMR for fast quantitative analysis: Application to tropine–nortropine mixtures by Giraudeau, Patrick, Guignard, Nadia, Hillion, Emilie, Baguet, Evelyne, Akoka, Serge

“…Quantitative analysis by 1H NMR is often hampered by heavily overlapping signals that may occur for complex mixtures, especially those containing similar…”
Get full text

Performances diagnostiques de la tomographie par émission de positons à la 18F-fluorocholine, pour l’identification préopératoire des parathyroïdes hyperfonctionnelles dans les hyperparathyroïdies primaires by Guignard, N., Gilly, O., Chambert, B., Sharara, H., Guedj, A.M., Lallemant, B.

“…La localisation pré opératoire des parathyroïdes pathologiques est cruciale pour une prise en charge chirurgicale efficace des hyperparathyroïdies primaires…”
Get full text

Ritonavir-boosted atazanavir-lopinavir combination : a pharmacokinetic interaction study of total, unbound plasma and cellular exposures by COLOMBO, Sara, BUCLIN, Thierry, CAVOSSINI, Matthias, FRANC, Claudia, GUIGNARD, Nicole, KHONKARLY, Mono, TARR, Philip E, ROCHAT, Bertrand, BIOLLAZ, Jérome, TELENTI, Amalio, DECOSTERD, Laurent A

“…To assess potential pharmacokinetic (PK) interactions between atazanavir (ATV, 300 mg, once daily) and lopinavir (LPV, 400 mg, twice daily), both boosted by…”
Get full text

Purification of simian virus 40 and JC T-antigens from transformed cells by Cikes, M, Beth, E, Guignard, N, Walker, D L, Padgett, B L, Giraldo, G

Get more information